Past Lessons Help Blood Operators Prepare for “Disease X”

Past Lessons Help Blood Operators Prepare for “Disease X”

If the blood community had a motto, it might be close to that of Scouting America’s: Be Prepared. That is why planning, preparedness, risk assessment and risk reduction for “Disease X” are always top of mind for the experts and organizations tasked with ensuring a safe and sufficient blood supply during the next emerging pathogen event.

“We are judged not on how well we do day to day, but during the emergencies,” said Jed Gorlin, MD, MBA, transfusion service medical director at Hennepin County Medical Center. “People may get annoyed that we are constantly saying ‘donate blood,’ but it is essential to have blood on the shelf. Any time blood is transfused in an emergency, it is blood that was donated at least several days before the emergency occurred. Preparedness is what we are all about.” 

Natural and human factors, such as climate change, human expansion and air travel, are creating an environment more capable than ever to support the next global emerging human pathogen event, and the risk for next emerging infectious disease (EID) is greater than ever. In fact, the World Health Organization has reported that since the 1970s, approximately 40 new infectious diseases have been discovered, including COVID-19, Zika, avian influenza and more.1 At the same time, risk for re-emerging diseases — such as measles and tuberculosis — has also increased.2 Fortunately, there are more tools than ever to help prepare for the next EID.

Log in to read the full article.

This article is reserved for AABB members.
Please log in or join AABB to continue reading.

Feature

By Leah Lawrence, Contributing Writer

May 2026

May 2026 View Issue


Find More News

transfusion journal

Transfusion Journal

Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.

Learn More About Transfusion Journal
CellSource

AN UPDATE ON THE LATEST BIOTHERAPIES NEWS

Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.

Read and Subscribe Today

CONTACT US

To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.

CONNECT WITH US

AABB News

President

Jose Cancelas, MD, PhD, CABP

Chief Executive Officer

Debra Ben Avram, FASAE, CAE

Chief Communications and Engagement Officer

Julia Zimmerman

Director of Marketing and Communications

Jay Lewis, MPH

Managing Editor

Kendra Y. Mims, MFA

Senior Communications Manager

Drew Case

AABB News

(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.

AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.

+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.

Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.

2025 APEX Awards for Publication Excellence